Home > News > Newly Appointed Alto Holdings CFO Gardner Takes Voting Control of Cancer Therapeutics Inc.
April 26th, 2010
Newly Appointed Alto Holdings CFO Gardner Takes Voting Control of Cancer Therapeutics Inc.
Abstract:
Cancer Therapeutics Inc. (OTC BB: CTHP) has issued 200 preferred shares to CEO-CFO Chene Gardner in lieu of one year's salary, giving him 70.39 percent voting control of the company, according to an 8-K filed today with the U.S. Securities and Exchange Commission.
Based in South Jordan, Utah, and with principal business offices in Thomasville, Ga., Cancer Therapeutics is a biotechnology business incubator that focuses on disruptive treatments and nanotechnology to develop drugs for the treatment of cancer.
Source:
citybizlist.com
| Related News Press |
News and information
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||